Elisabeth Bloemena
Overview
Explore the profile of Elisabeth Bloemena including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
132
Citations
2661
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wils L, Poell J, Peferoen L, Evren I, Brouns E, de Visscher J, et al.
J Oral Pathol Med
. 2023 Sep;
52(10):930-938.
PMID: 37749621
Objective: Oral leukoplakia is the most common oral potentially malignant disorder. Malignant transformation of oral leukoplakia occurs at an annual rate of 1%-7%. WHO-defined classic epithelial dysplasia is an important...
12.
Wils L, Poell J, Brink A, Evren I, Brouns E, de Visscher J, et al.
Clin Cancer Res
. 2022 Nov;
29(3):602-613.
PMID: 36449687
Purpose: Oral leukoplakia is the most common oral potentially malignant disorder with an annual malignant transformation rate of 1% to 5%. Consequently, oral leukoplakia patients have a 30% to 50%...
13.
Kashyap B, Naumanen K, Mikkonen J, Dekker H, Schulten E, Bloemena E, et al.
Biomedicines
. 2022 Nov;
10(11).
PMID: 36359337
It is well established that cancer cells exploit aberrant synthesis of mucin 1 (MUC1) and hyaluronan (HA) synthesis along with HA's physiological cell surface receptor CD44. However, their role in...
14.
Poell J, Wils L, Brink A, Dietrich R, Krieg C, Velleuer E, et al.
Int J Cancer
. 2022 Sep;
152(2):227-238.
PMID: 36069231
Oral squamous cell carcinomas (OSCCs) develop in genetically altered epithelium in the mucosal lining, also coined as fields, which are mostly not visible but occasionally present as white oral leukoplakia...
15.
Kashyap B, Mikkonen J, Bhardwaj T, Dekker H, Schulten E, Bloemena E, et al.
Arch Oral Biol
. 2022 Aug;
142:105525.
PMID: 36027639
Objectives: The aim of this study was to assess the MUC1 expression in the oral epithelium of normal, oral epithelial dysplasia (OED), oral squamous cell carcinoma (OSCC), and irradiated oral...
16.
Brouns E, Evren I, Wils L, Poell J, Brakenhoff R, Bloemena E, et al.
Oral Dis
. 2022 Jun;
29(7):2667-2676.
PMID: 35765231
Objectives: A classification and staging system for oral leukoplakia (OL) was introduced to promote uniform reporting. In this system, size and the histopathologic diagnosis are assessed and combined in a...
17.
Dekker H, Schulten E, Lichters I, van Ruijven L, van Essen H, Blom G, et al.
Adv Radiat Oncol
. 2022 Jun;
7(4):100951.
PMID: 35662809
Purpose: To assess the effect of radiation therapy on osteocyte apoptosis, osteocyte death, and bone marrow adipocytes in the human mandible and its contribution to the pathophysiology of radiation damage...
18.
Butter R, Hondelink L, van Elswijk L, Blaauwgeers J, Bloemena E, Britstra R, et al.
Lung Cancer
. 2022 Mar;
166:143-149.
PMID: 35279453
Objectives: Programmed death-ligand 1 (PD-L1) is the only approved predictive biomarker for immunotherapy in non-small cell lung cancer (NSCLC). However, predictive PD-L1 immunohistochemistry is subject to interobserver variability. We hypothesized...
19.
Schoonbeek R, de Jel D, van Dijk B, Willems S, Bloemena E, Hoebers F, et al.
Radiother Oncol
. 2022 Feb;
169:146-147.
PMID: 35101464
No abstract available.
20.
van Weert S, Valstar M, Lissenberg-Witte B, Bloemena E, Smit L, van der Wal J, et al.
Oral Oncol
. 2022 Jan;
125:105698.
PMID: 34973520
Introduction: The aim was to analyse prognosticators in acinic cell carcinoma (AciCC) in two head and neck referral centers in Amsterdam, the Netherlands. Materials And Methods: Eighty- nine cases of...